Members of the World Health Organization have adopted a landmark agreement on how to prepare for future pandemics following ...

The LP.8.1 variant of the SARS-CoV-2 virus differs from the JN.1 family that previous vaccines had been designed to target, ...

Up to 20% of such products would be given to the WHO to ensure poorer countries have some access to them when the next ...

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Southeast Asia sees a rise in COVID-19 cases due to new Omicron subvariants. Experts say most cases are mild, but precautions ...

A fresh wave of Covid-19 has been reported across Asia including countries like Singapore, Hong Kong, China and Thailand.

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

US FDA approves Novavax’s BLA for Covid-19 vaccine, Nuvaxovid: Gaithersburg, Maryland Tuesday, May 20, 2025, 14:00 Hrs [IST] Novavax, Inc. announced that the US Food and Drug Ad ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.